Medtech in 2021: Equipping for a Post-COVID-19 Rebound
In 2021, medtech will grapple with ways to capture the pandemic rebound opportunity through value-adding new technologies and responsiveness to the complexities and diversity of the shifting US healthcare system. In late January, a panel of experts spoke with MedTech Strategist about these challenges.
Read Article